Health Catalyst, Inc.
General ticker "HCAT" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $291.3M (TTM average)
Health Catalyst, Inc. does not follow the US Stock Market performance with the rate: -1.3%.
Estimated limits based on current volatility of 5.6%: low 2.71$, high 3.02$
Factors to consider:
- Total employees count: 1500 as of 2024
- Top business risk factors: Economic downturns and volatility, Market competition, Strategic risks and growth management, Client transition risks, Funding access
- Current price 44.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.85$, 9.61$]
- 2025-12-31 to 2026-12-31 estimated range: [4.72$, 9.42$]
Financial Metrics affecting the HCAT estimates:
- Positive: with PPE of 25.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 41.86 < Shareholder equity ratio, % of 42.52 <= 63.39
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -14.38 < Investing cash flow per share per price, % of -5.40
Short-term HCAT quotes
Long-term HCAT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $276.24MM | $295.94MM | $306.58MM |
| Operating Expenses | $416.24MM | $422.83MM | $376.39MM |
| Operating Income | $-140.00MM | $-126.90MM | $-69.81MM |
| Non-Operating Income | $-1.68MM | $9.11MM | $0.64MM |
| R&D Expense | $75.68MM | $72.63MM | $57.95MM |
| Income(Loss) | $-141.68MM | $-117.79MM | $-69.17MM |
| Taxes | $-4.28MM | $0.36MM | $0.33MM |
| Profit(Loss)* | $-137.40MM | $-118.15MM | $-69.50MM |
| Stockholders Equity | $425.01MM | $366.92MM | $365.21MM |
| Assets | $752.29MM | $701.81MM | $858.93MM |
| Operating Cash Flow | $-35.27MM | $-33.08MM | $14.56MM |
| Capital expenditure | $17.41MM | $14.31MM | $16.40MM |
| Investing Cash Flow | $-39.02MM | $20.29MM | $-22.90MM |
| Financing Cash Flow | $-2.61MM | $2.73MM | $151.75MM |
| Earnings Per Share** | $-2.56 | $-2.09 | $-1.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.